Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lambert-Eaton-Syndrome”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableEnrolling By InvitationNCT06605612
What this trial is testing

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more
LMU Klinikum 108
Not applicableUnknownNCT06441825
What this trial is testing

Patient Observation With Environmental and Wearable Sensors in Myasthenia Gravis

Who this might be right for
Myasthenia GravisMyasthenic SyndromeLambert-Eaton Myasthenic Syndrome
Heinrich-Heine University, Duesseldorf 20
Not applicableLooking for participantsNCT06630650
What this trial is testing

A Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes

Who this might be right for
Myasthenic Syndromes, Congenital
National Institute of Neurological Disorders and Stroke (NINDS) 75
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Not applicableNo Longer AvailableNCT01765140
What this trial is testing

Treatment Use of 3,4-Diaminopyridine

Who this might be right for
Myasthenic Syndromes, Congenital
Vern C. Juel, M.D.
Not applicableNo Longer AvailableNCT02012933
What this trial is testing

3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)

Who this might be right for
Lambert-Eaton Myasthenic Syndrome (LEMS)Congenital Myasthenia (CM)
Oregon Health and Science University
Early research (Phase 1)Not Yet RecruitingNCT07830563
What this trial is testing

Evaluating the Safety and Effects of AMP-101 in People With DOK7 Congenital Myasthenia Syndrome

Who this might be right for
Congenital Myasthenia Syndrome
Amplo Biotechnology 4
Not applicableApproved For MarketingNCT00872950
What this trial is testing

3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)

Who this might be right for
Lambert-Eaton Myasthenic SyndromeCongenital Myasthenic Syndrome
Lahey Clinic
Not applicableNo Longer AvailableNCT01378546
What this trial is testing

Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP

Who this might be right for
Lambert Eaton Myasthenic Syndrome (LEMS)
Louis H. Weimer, MD
Not applicableApproved For MarketingNCT02189720
What this trial is testing

Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome

Who this might be right for
Congenital Myasthenic SyndromeLambert-Eaton Myasthenic SyndromeNystagmus, Acquired
Catalyst Pharmaceuticals, Inc.
Not applicableWithdrawnNCT07075627
What this trial is testing

Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer ( SCLC )Lambert Eaton Myasthenic Syndrome (LEMS)
Addario Lung Cancer Medical Institute
Not applicableNo Longer AvailableNCT01373333
What this trial is testing

Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome

Who this might be right for
Lambert-Eaton Myasthenic Syndrome
The Cleveland Clinic
Testing effectiveness (Phase 2)Active Not RecruitingNCT00716066
What this trial is testing

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Who this might be right for
Autoimmune DiseaseNeurologic Autoimmune DiseaseAutologous Transplant Autoimmune+16 more
Fred Hutchinson Cancer Center 53
Not applicableNo Longer AvailableNCT03062631
What this trial is testing

Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia

Who this might be right for
Congenital Myasthenic Syndrome
Ricardo Maselli
Not applicableLooking for participantsNCT07136844
What this trial is testing

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Who this might be right for
Neuromuscular DiseasesObesity (Disorder)Myotonic Dystrophy 1+9 more
Centre Hospitalier Universitaire de Liege 300
Early research (Phase 1)Looking for participantsNCT07226726
What this trial is testing

Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution

Who this might be right for
Congenital Myasthenic Syndrome
The Foundation for Orthopaedics and Regenerative Medicine 20
Not applicableLooking for participantsNCT07478172
What this trial is testing

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Who this might be right for
Neuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more
University of Missouri-Columbia 50
Not applicableApproved For MarketingNCT01825395
What this trial is testing

Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome

Who this might be right for
Lambert Eaton Myasthenic Syndrome
University of Colorado, Denver
Large-scale testing (Phase 3)Study completedNCT01377922
What this trial is testing

Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

Who this might be right for
Lambert Eaton Myasthenic Syndrome
Catalyst Pharmaceuticals, Inc. 38
Testing effectiveness (Phase 2)Study completedNCT01511978
What this trial is testing

Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome

Who this might be right for
Lambert-Eaton Myasthenic SyndromeEaton-Lambert Myasthenic Syndrome
Jacobus Pharmaceutical 32
Next Page